Medtronic MiniMed, Inc. is recalling 8,251 units of the InPen App (Model MMT-8061) for Android users. A software issue occurs when the app is uninstalled and then reinstalled, causing the setup screen for notification styles to be skipped. This defect prevents users from choosing to allow insulin notifications to override phone settings like mute or 'Do Not Disturb,' which can result in critical audible or vibrating alerts not being received. If you use this app, you should contact Medtronic or your healthcare provider to ensure your notification permissions are correctly configured.
Missing audible or vibrating notifications for insulin therapy can lead to delayed treatment and high blood sugar (hyperglycemia). This software defect specifically deletes previously set override permissions, making the device silent even when the user expects to be alerted during muted or quiet phone modes.
You have 2 options:
Recall affects users who have uninstalled and reinstalled the application.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.